Ketohexokinase (EC 2.7.1.3) was purified to homogeneity from human liver, and fructose-bisphosphate aldolase (EC 4.1.2.13) was partially purified from the same source. Ketohexokinase was shown, by column chromatography and polyacrylamidegel electrophoresis, to be a dimer of Mr 75 000. Inhibition studies with pchloromercuribenzoate and N-ethylmaleimide indicate that ketohexokinase contains thiol groups, which are required for full activity. With D-xylulose as substrate, ketohexokinase and aldolase can catalyse a reaction sequence which forms glycolaldehyde, a known precursor of oxalate. The distribution of both enzymes in human tissues indicates that this reaction sequence occurs mainly in the liver, to a lesser extent in the kidney, and very little in heart, brain and muscle. The kinetic properties of ketohexokinase show that this enzyme can phosphorylate D-xylulose as readily as D-fructose, except that higher concentrations of D-xylulose are required. The kinetic properties of aldolase show that the enzyme has a higher affinity for Dxylulose 1-phosphate than for D-fructose 1-phosphate. These findings support a role for ketohexokinase and aldolase in the formation of glycolaldehyde. The effect of various metabolites on the activity of the two enzymes was tested to determine the conditions that favour the formation of glycolaldehyde from xylitol. The results indicate that few of these metabolites affect the activity of ketohexokinase, but that aldolase can be inhibited by several phosphorylated compounds. This work suggests that, although the formation of oxalate from xylitol is normally a minor pathway, under certain conditions of increased xylitol metabolism oxalate production can become significant and may result in oxalosis.
Ketohexokinase (EC 2.7.1.3) was purified to homogeneity from human liver, and fructose-bisphosphate aldolase (EC 4.1.2.13) was partially purified from the same source. Ketohexokinase was shown, by column chromatography and polyacrylamidegel electrophoresis, to be a dimer of Mr 75 000. Inhibition studies with pchloromercuribenzoate and N-ethylmaleimide indicate that ketohexokinase contains thiol groups, which are required for full activity. With D-xylulose as substrate, ketohexokinase and aldolase can catalyse a reaction sequence which forms glycolaldehyde, a known precursor of oxalate. The distribution of both enzymes in human tissues indicates that this reaction sequence occurs mainly in the liver, to a lesser extent in the kidney, and very little in heart, brain and muscle. The kinetic properties of ketohexokinase show that this enzyme can phosphorylate D-xylulose as readily as D-fructose, except that higher concentrations of D-xylulose are required. The kinetic properties of aldolase show that the enzyme has a higher affinity for Dxylulose 1-phosphate than for D-fructose 1-phosphate. These findings support a role for ketohexokinase and aldolase in the formation of glycolaldehyde. The effect of various metabolites on the activity of the two enzymes was tested to determine the conditions that favour the formation of glycolaldehyde from xylitol. The results indicate that few of these metabolites affect the activity of ketohexokinase, but that aldolase can be inhibited by several phosphorylated compounds. This work suggests that, although the formation of oxalate from xylitol is normally a minor pathway, under certain conditions of increased xylitol metabolism oxalate production can become significant and may result in oxalosis.
There has been renewed interest in the pathways for the metabolism ofsugars and sugar alcohols. For example, Williams and co-workers (Williams, 1980; Williams et al., 1984; Bleakley et al., 1984) have stimulated intense debate (Rognstad et al., 1982; Landau & Wood, 1983) with their formulation of a second pentose phosphate pathway. The enzymes for the metabolism of sugar alcohols in human brain have been described (O'Brien & Schofield, 1980; O'Brien et al., 1983) . Xylitol is generally considered to be metabolized via the glucuronate-xylulose and pentose phosphate pathAbbreviation used: SDS, sodium dodecyl sulphate. * To whom correspondence and reprint requests should be addressed.
ways, but its metabolism, both in vivo and in vitro, has been associated with the production of oxalate and known oxalate precursors (Hannett et al., 1977; Rofe et al., 1977 Rofe et al., , 1979 Rofe et al., , 1980 Hauschildt & Brand, 1979) .
Only recently has a satisfactory metabolic pathway been proposed to explain oxalate production from xylitol. D-Xylulose, which can be formed from xylitol by the enzyme polyol dehydrogenase (Hollman & Touster, 1957; Arsenis & Touster, 1969; O'Brien et al., 1983) (James et al., 1982) . Independently, it has also been shown that the same reactions can be catalysed by bovine liver ketohexokinase and rat liver aldolase and that xylulose 1-phosphate is produced in isolated hepatocytes that are metabolizing xylulose (Barngrover et al., 1981; Barngrover & Dills, 1983) .
The present paper describes the purification of ketohexokinase and aldolase from human liver and examines their properties. In addition, the activity of these enzymes has been studied to determine the conditions under which the metabolism of xylitol will favour the production of the oxalate precursor, glycolaldehyde.
Materials
Human tissues were obtained from the Division of Tissue Pathology in our Institute. The tissues were macroscopically free of disease and taken, within 24h of death, from cadavers which had been stored at 4°C. The (Ames, 1966) , xylulose 1-phosphate (Barngrover et al., 1981) , fructose 1 ,6-bisphosphate (Michal & Beutler, 1974) and glycolaldehyde (Datta & Racker, 1961 (James et al., 1982) .
All enzyme assays were carried out at 37°C.
Homogenates for enzyme assays Tissues were rinsed with cold 0.9% (w/v) NaCl to remove blood, cut into thin slices and placed in 50mM-triethanolamine/HCI buffer, pH7.5, containing 250mM-sucrose, 5mM-EDTA, 10mM-MgCl2 and 25mM-2-mercaptoethanol. Liver, kidney and brain extracts were prepared with three passes of a loosely fitting Teflon pestle in a glass homogenizer, and heart and skeletal muscle were homogenized for 2 x 15 s in a Sorvall Omni-Mixer. Assays were performed on the supernatant fractions which were obtained by immediate centrifugation of the homogenate at 15000g for 20min at 4°C. For the measurement of ketohexokinase activity in these crude supernatant fractions, the assay contained, in 20mM-triethanolamine/HCl buffer, pH7.5: lOOmM-KCl, 20mM-MgCl2, 15mM-ATP, 0.6mM-NADH, 16mM-NaF (to inhibit ATPase activity), 1Ounits of aldolase/ml, 8 units of glycerol-3-phosphate dehydrogenase/ml, 2 units of glycerokinase/ml and 60 units of alcohol dehydrogenase/ml. Depending on which substrate is used, the assay measures the glyceraldehyde or glycolaldehyde formed with alcohol dehydrogenase and NADH. However, because dihydroxyacetone phosphate inhibits aldolase, this is removed by using glycerol-3-phosphate dehydrogenase and glycerokinase. This modified assay system was necessary because, if the ATP depletion was monitored, there are several reactions which would contribute to the apparent ketohexokinase activity, including hexokinase and phosphofructokinase if fructose was the substrate and xylulokinase if xylulose was the substrate.
Protein assays
Protein concentration was determined by the procedure of Lowry et al. (1951) , except that the protein was first precipitated with 5vol. of 10% (w/v) trichloroacetic acid to prevent interference by sucrose, EDTA or 2-mercaptoethanol. The relative amounts of protein in the column effluents were estimated from the A280.
Purification of human liver ketohexokinase
Human liver ketohexokinase was prepared by a modification of the methods used to prepare the rat (Sanchez et al., 197 la) and ox (Raushel & Cleland, 1977) liver enzymes (see Table 1 ). All purification steps were carried out at 4°C. The Chromatofocusing purification step was performed as described by Sluyterman & Elgersma (1978) . The enzyme was then concentrated with an Amicon concentrator and dialysed against l0mM-Tris/HCl buffer, pH6.0. The dialysis residue was loaded on a Blue Sepharose column (21 cm x 1.3cm) and the ketohexokinase activity was eluted with the same buffer. The fractions containing ketohexokinase were pooled and the pH was adjusted to 7.2. They were then concentrated with an Amicon concentrator and stored at -20°C. Purification of human liver aldolase Human liver aldolase was prepared by the procedure described by Eagles & Iqbal (1973) , with the following modification. After passage through the CM-cellulose 11 column, the protein was precipitated with 60%-satn. (NH4)2SO4 and the precipitate chromatographed on a Sephacryl S-200 column (96cm x 3.4cm), which was equilibrated with l0mM-triethanolamine/HCl buffer, pH7.3. The fractions containing aldolase activity were pooled, concentrated with an Amicon concentrator and stored frozen at -20°C.
Results

Purification of ketohexokinase and aldolase
The results for the preparation of ketohexokinase from human liver are shown in Table 1 . The final specific activity of the ketohexokinase is similar to that reported for both the ox (Raushel & Cleland, 1977) and rat (Sanchez et al., 1971a) liver enzymes. The enzyme appears to be homogeneous when examined by polyacrylamide-gel electrophoresis under both denaturing and non-denaturing conditions (Fig. 1) . It is necessary to perform more column-chromatography steps in this preparation than were described for the ox liver enzyme. This is because a greater amount of protein is obtained in the initial step of the human liver preparation than in the ox liver extraction without there being any increase in the total ketohexokinase activity.
The aldolase preparation was examined by polyacrylamide-gel electrophoresis, and is not homogeneous (results not shown), but, using Sephacryl S-200 column chromatography, we have found that the enzyme has a Mr of 150 000, which is (Peanasky & Lardy, 1958; Gracy et al., 1969) . Other physical properties of the enzyme are the same as have been described previously (Eagles & Iqbal, 1973) .
These two enzyme preparations were assayed for the following enzymic activities, which could possibly interfere with the system that we are measuring: glycerol-3-phosphate dehydrogenase, polyol dehydrogenase, triosephosphate isomerase, ATPase, glucokinase, phosphofructokinase, alcohol dehydrogenase and lactate dehydrogenase. There was no detectable activity of any of these enzymes in either enzyme preparation. Physical properties of ketohexokinase The M, of the enzyme as determined by column chromatography on Sephadex G-100 and Sephacryl S-200 is 75000. Polyacrylamide-gel electrophoresis in non-denaturing conditions (Davis, 1964) and electrophoresis in the presence of SDS (Weber & Osborn, 1969) both indicate that the enzyme runs as a single protein band (Fig. 1) . The protein migrates between malate dehydrogenase (37000) and ovalbumin (43000) on SDS gels and corresponds to a Mr of 39000. Thus the results indicate that the human liver enzyme is a dimer with subunits of M, 39000. The pI obtained on the Chromatofocusing column for the enzyme is 5.5 (Fig. 2) and is similar to the value of 5.7 obtained for the ox liver enzyme by isoelectric focusing in polyacrylamide gels (Raushel & Cleland, 1977) . No metal ions and, in particular, no zinc, magnesium, copper or calcium could be detected in the ketohexokinase preparation by either Energy Dispersion Analysis of X-rays (Woldseth, 1973) or atomic-adsorption spectrophotometry.
The effect of thiol reagents (dithiothreitol, Nacetylcysteine and 2-mercaptoethanol) and EDTA on the stability of ketohexokinase was studied by diluting the partially purified enzyme in 20mM-triethanolamine/HCI buffer, pH 7.2, containing 10mM effector. We found that the enzyme was stable for at least 48 h, after which time the activity decreased in the presence of N-acetylcysteine and 2-mercaptoethanol, but to a lesser extent than that which occurred with buffer alone. Ketohexokinase can be inhibited by p-chloromercuribenzoate (Adelman et al., 1967; Sanchez et al., 1971a) , and this indicates that the enzyme has an absolute requirement for a thiol group. However, the results obtained by Adelman et al. (1967) , using iodoacetate and iodoacetamide, are contradictory and do not support this conclusion. To study whether there is an essential thiol group present in the enzyme, we used not onlyp-chloromercuribenzoate but also N-ethylmaleimide, which is considered to be a more specific inactivator of thiol groups The polyacrylamide gels are (1) the pH 8.6 system described by Davis (1964) and (2-4) the SDS system described by Weber & Osborn (1969) . The samples are (1) and (2) ketohexokinase, (3) ovalbumin marker (Mr 43000) and (4) malate dehydrogenase subunit marker (M, 37000). For the non-denaturing gel electrophoresis, 60ug of protein was diluted with gel buffer containing 20% sucrose and then loaded on the gel. For the SDS/polyacrylamide-gel electrophoresis, 60pg of protein was incubated overnight with an equal volume of electrophoresis buffer containing I mM-2-mercaptoethanol. Electrophoresis conditions were as described in the text. (Morell et al., 1964 Tube number Fig. 2 . Purification of human liver ketohexokinase on a Chromatofocusing column The partially purified protein was loaded on the Chromatofocusing column, which had been equilibrated with 25mM-imadazole/HCl buffer, pH7.0. The activity was eluted with Polybuffer, pH4.0. The flow rate was 40ml/h, and 4ml fractions were collected. Protein was monitored by measuring A280 (@). Ketohexokinase activity (A) was measured by the spectrophotometric assay as described in the text. *, pH. (Adelman et al., 1967; Raushel & Cleland, 1977 (Gurtler et al., 1971; Eagles & Iqbal, 1973) , but the ratio of the Vmax values for these two substrates is slightly higher.
Tissue distribution of ketohexokinase and aldolase
The distribution of ketohexokinase and aldolase in various human tissues is shown in Table 3 . Ketohexokinase activity is highest in the liver and kidney, with very little activity in the other tissues tested. Aldolase, however, is more widely distributed, with considerable activity in muscle. The activity of ketohexokinase and aldolase in the liver is similar to that previously reported (Heinz et al., 1968 which is a direct precursor of oxalate (James et al., 1982; Barngrover et al., 1981) . The validity of this pathway has been shown by measuring the formation of the products from xylulose and fructose (James et al., 1982) . There are several enzymes with the potential to interfere with this series of reactions (see above), but we could not detect them in our enzyme preparations. The time course for the coupled reaction of ketohexokinase and aldolase with either fructose or xylulose as the initial substrate is shown in Fig. 3 . The results are non-linear, which is to be expected for a coupled enzyme system (McClure, 1969; Garcia-Carmona et al., 1981) , and the size of the lag can be varied by changing the aldolase concentration. In addition, we have shown, in vitro, the formation of oxalate from xylitol. This sequence of reactions was carried out with enzymes purified from several different sources, namely sheep liver sorbitol dehydrogenase, human liver ketohexokinase and aldolase, yeast aldehyde dehydrogenase, spinach glycollate oxidase and rabbit muscle lactate dehydrogenase. As cofactors, 10mM-ATP, 5mM-NAD+ and 5mM-FMN were added and, although the incorporation of radioactivity into oxalate from labelled xylitol was low, it was comparable with the amount of oxalate produced from xylitol by isolated hepatocytes .
We have measured the effect of a range of metabolites (10mM) on the activity of both ketohexokinase and aldolase. Initial investigations with ketohexokinase were carried out by the spectrophotometric assay, with fructose (25 and 1 mM) and xylulose (1 mM) as substrates. When there was a change in the activity, the radioactive assay, with fructose as the substrate, was used, as this eliminates any possible effects of the metabolites on the auxiliary enzymes. For aldolase with fructose 1,6-bisphosphate, fructose 1-phosphate and xylulose 1-phosphate (all at 20 x Km) as substrates, the activity can be measured with either alcohol dehydrogenase or glycerol-3-phosphate dehydrogenase as the linking enzyme. If there was any change in the activity of the aldolase assay, the The reaction mixtures were essentially as described in the text with the initial substrate concentration being 10mM-fructose (-) or -xylulose (M). Reactions were initiated by the addition of substrate and monitored at 340nm. effect was tested by both of these auxiliary enzyme systems.
These studies showed that, of the intermediates involved in the sequence of reactions which form oxalate from xylulose (James et al., 1982) , only glyoxylate had any effect on either ketohexokinase or aldolase. Amino acids and C5 and C6 aldoses, ketoses and polyols had no effect on the activity of either enzyme. Of the other compounds tested, Ca2+, ADP and citrate had a significant effect on the ketohexokinase activity. The Ca2+ probably competes with Mg2+ for the ATP, citrate complexes essential metal ions (e.g. K+) (Sanchez et al., 1971b) , and ADP inhibition has been reported previously (Raushel & Cleland, 1977) . We also confirmed the last authors' observation of inhibition by fructose 1-phosphate, but the inhibition constant is high and probably has no physiological significance.
Our inhibitor studies with human liver aldolase gave similar results to those described by Woods et al. (1970) . They used purified rat liver aldolase and found that several phosphorylated metabolites inhibit the enzymic activity and that, when fructose 1-phosphate (or, as in our studies, xylulose 1-phosphate as well) is a substrate, aldolase is more sensitive to inhibition than when fructose 1,6-bisphosphate is a substrate. The phosphorylated intermediates that caused marked inhibition included glucose 1-phosphate, glucose 6-phosphate, fructose 6-phosphate, ribose 5-phosphate, erythrose 4-phosphate, glycerol 2,3-bisphosphate, ATP, ADP and IMP. Aldolase was also inhibited by ascorbic acid, with a concentration of 1 mM causing 50% inhibition. Consideration of the structure of ascorbic acid and the substrates of aldolase suggest that this effect is due to a steric hindrance by ascorbic acid. It is unlikely, however, that ascorbic acid concentration in vivo would be this high, even in association with mega-dose intakes. The other inhibitor of the activity is glyoxylate, but its mechanism of action is unclear.
Discussion
The procedure reported here for the purification of ketohexokinase from human liver results in the isolation of a homogeneous enzyme preparation. Column chromatography and polyacrylamide-gel electrophoresis indicate that the enzyme is a dimer of Mr 75000. Other workers have shown rat liver ketohexokinase to be a monomer of M, 28000 (Sanchez et al., 1971a) and the ox liver enzyme to be a dimer of M, 56000 (Raushel & Cleland, 1977 Stability studies on crude extracts of ketohexokinase and the partially purified enzyme give different results and showed that only the purified enzyme could be stabilized by N-acetylcysteine or 2-mercaptoethanol. One explanation for these contradictory results is that in the crude extracts, proteinases, which are known to be present in the liver at high concentrations, are released during the extraction procedure and are activated by the thiol reagents or the EDTA. To minimize this problem, phenylmethanesulphonyl fluoride, a proteinase inhibitor, was added to the extraction buffer. With the purified enzyme the presence of thiol groups is required for full catalytic activity, and these groups are most likely to be at the active site of the enzyme (or immediately adjacent to it), because the inactivation could be partially prevented by the substrate, fructose.
Ketohexokinase is most abundant in the liver. The kidney has about half the activity present in the liver, and there are very low activities present in the brain, heart and muscle. These findings agree with the results obtained for the distribution of the enzyme in the rat (Adelman et al., 1967) , and our results for the activity in human liver are similar to that found by Heinz et al. (1968) . In all the human organs tested, the activities with both fructose and xylulose as substrates are very similar, and the liver must be the major organ for xylitol metabolism. It has been claimed by several authors that xylitol can be metabolized by tissues other than liver and kidney, but it is very difficult to ascertain from results of experiments in vivo whether one is monitoring the metabolism of xylitol itself or the metabolism of glucose after the liver has converted xylitol into glucose.
Xylulose is the oxidation product of the hepatic NAD-dependent xylitol dehydrogenase, and under normal circumstances this compound can be phosphorylated by xylulokinase to xylulose 5-phosphate (Arsenis & Touster, 1969) , which enters the pentose phosphate pathway, and then the glycolytic-gluconeogenic pathway to form glucose, pyruvate and lactate.
The results described above indicate that xylitol can, in addition, be metabolized through xylulose 1-phosphate to glycolaldehyde, a known oxalate precursor. Barngrover & Dills (1983) concluded that the production of xylulose from xylitol is so slow that xylulokinase never becomes saturated and that the xylulose concentration would not reach values sufficient for extensive phosphorylation by ketohexokinase. The relatively high Km of liver ketohexokinase for xylulose would also support this conclusion. However, xylulose 1-phosphate and glycolaldehyde are produced in isolated hepatocytes treated with xylulose, indicating that this is a minor pathway of xylitol metabolism. The proposed pathway can explain the production of oxalate from xylitol observed in isolated hepatocytes, especially since the amount Vol. 230 of oxalate produced is less than 0.2% of the xylitol utilized (Rofe et al., 1980) . These studies are important in that they provide a biochemical explanation for the clinical observation that a number of patients receiving xylitol, as an intravenous nutrient, developed adverse reactions, including the deposition of calcium oxalate in the kidney, brain, lung and vascular tissues, and this resulted in the death of some of these patients (Thomas et al., 1972; Schr6der, 1980) . However, the liver is the major site of oxalate production (Liao & Richardson, 1972; Richardson, 1973) and, in xylitol toxicity, it would appear that the oxalate is produced in the liver, and transported to the nonhepatic tissues in which the deposition occurs. It is clear that the production of oxalate from xylitol is a relatively minor pathway, but in situations of excessive xylitol intake, such as parenteral infusion, it does become important.
